Eli Lilly & Co. Zepbound injection pens arranged in a tray. Photographer: Shelby Knowles/Bloomberg © 2024 Bloomberg Finance LP Eli Lilly’s decision to sell its obesity drug Zepbound directly to patients for $499 per month—well below the $2,000 list …

… industrial collaboration, India’s pharmaceutical companies have been invited to explore … between Saudi firms and international pharma companies, a model that Indian … government-led investment programs and healthcare reforms, sector-specific opportunities in …

Pat Ryan U.S. House of Representatives from New York | Official U.S. House HeadshotPat Ryan U.S. House of Representatives from New York | Official U.S. House Headshot Rep. Pat Ryan, a member of the U.S. Congress representing New York's 18th District …

(The Center Square) – During a Senate hearing on Robert F. Kennedy Jr.’s nomination for Secretary of Health and Human Services (HHS), Republican North Carolina Senator Thom Tillis expressed optimism about Kennedy’s potential leadership. “I hope he goes …

Rep. Chip Roy Press Office, representing Texas’ 21st district in the U.S. Congress, has recently shared a series of tweets addressing key issues in American healthcare and systemic problems within the industry. The tweets highlight his perspectives on …

… rely on foreign governments, multinational pharmaceutical companies, or imported goods.  There … prices often set by global pharmaceutical companies, making healthcare more affordable … Essentially, the system needs both healthcare reforms and a way to tackle …

… entities act as intermediaries between drugmakers and the consumer market and … good first step towards delivering drugmaker rebates to patients as financial … people’s business. Getting incremental healthcare reform efforts across the finish line …

If there is an area in which the US and China can compete for the productive benefit of their citizens, it is healthcare. The rival powers have healthcare sectors with much that needs fixing. While their problems are shaped by different causes, they have …

… and their political allies. Major healthcare reform happened before, and it can … as monopolies granted to big pharmaceutical companies and simultaneously prevent policies such …

… he proposed, including his modest health-care reform law, “socialism.” Over the last … , and say profits made by pharmaceutical companies are a “major factor” in …